DNA Diagnostics Market Key Highlights:
- Market Size (2024): USD 27.10 Billion
- Projected Market Size (2034): USD 57.96 Billion
- CAGR (2024-2034): 7.9%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
DNA Diagnostics Market Definition
The DNA diagnostics market deals with the utilization of DNA diagnostics to detect genetic markers and variations that may be associated with inherited disorders, medical conditions, and traits. The rise in investment in R&D for inherited disorders and advancements in genomics and bioinformatics is driving market growth.
- In November 2024, ProPhase Labs, Inc. a next-generation biotech, genomics, and diagnostics company, announced the launch of DNA Complete, Inc., a wholly owned subsidiary, providing a groundbreaking direct-to-consumer DNA test.
The substantial concerns about privacy and ethics that arise from integrating DNA tests into treatment are posing to hamper market growth. To resolve these privacy risks data anonymization techniques should be used. Despite these restraints, the increasing utilization of precision medicine diagnostic techniques can boost market growth shortly.
- In November 2023, Illumina launched an innovative liquid biopsy assay to enable comprehensive genomic profiling of solid tumours.
DNA Diagnostics Market Segmentation:
By Product
- Instruments
- Reagents
- Software & Services
By Technology
- PCR-based
- Microarray-based
- In-situ Hybridization-based
- Sequencing Technology-based
- Mass Spectrometry-based
By Application
- Oncology
- Infectious Diseases Treatment
- Myogenic Disorder Treatment
- Clinical Diagnostic Confirmation
- Prenatal
- Pre-Implantation
- Other Applications
By End User
- Point of Care
- Diagnostic Centers
- Self-Testing/OTC
DNA Diagnostics Market Companies:
- GE Healthcare
- Abbott
- Beckman Coulter Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Cepheid.
- Hologic, Inc.
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche
- QIAGEN
- Agilent Technologies Inc.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
